Benchmark Starts Omnicell (OMCL) at Buy, $19 PT

January 25, 2013 7:03 AM EST Send to a Friend
Get Alerts OMCL Hot Sheet
Price: $31.80 -0.59%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 51
Trade OMCL Now!
Join SI Premium – FREE
Benchmark initiates coverage on Omnicell (NASDAQ: OMCL) with a Buy. PT $19.00.

The firm comments, "We are initiating coverage of Omnicell at Buy with a $19 price target based on an 18x multiple of $1.05 in EPS we forecast this year. Omnicell offers a good mix of visibility from 80% recurring revenue, and attractive 15%-20% forecast earnings growth, in our view. We anticipate long term expanding demand for Omnicell’s medication management systems to control costs and improve healthcare quality by automating manual tasks. The 2012 MTS acquisition opens new markets and demonstrates the accretive power of leveraging Omnicell’s strong free cash flow."

For an analyst ratings summary and ratings history on Omnicell click here. For more ratings news on Omnicell click here.

Shares of Omnicell closed at $15.57 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Earnings

Add Your Comment